These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33357391)

  • 21. COVID-19 Laboratory Testing/CDC Guidelines.
    McFee DRB
    Dis Mon; 2020 Sep; 66(9):101067. PubMed ID: 32883517
    [No Abstract]   [Full Text] [Related]  

  • 22. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculosis and COVID-19 in India- double trouble!
    Iyengar KP; Jain VK
    Indian J Tuberc; 2020 Dec; 67(4S):S175-S176. PubMed ID: 33308667
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-dose chest CT had 95% sensitivity and 91% specificity for diagnosing COVID-19 in patients with clinical symptoms.
    Long B
    Ann Intern Med; 2020 Dec; 173(12):JC68. PubMed ID: 33316180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).
    Ryan DJ; Toomey S; Madden SF; Casey M; Breathnach OS; Morris PG; Grogan L; Branagan P; Costello RW; De Barra E; Hurley K; Gunaratnam C; McElvaney NG; OBrien ME; Sulaiman I; Morgan RK; Hennessy BT
    Thorax; 2021 Jan; 76(1):86-88. PubMed ID: 33097604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
    Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
    Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions.
    Bell KJ; Stanaway FF; Irwig LM; Horvath AR; Teixeira-Pinto A; Loy C
    Med J Aust; 2021 Feb; 214(2):69-73.e1. PubMed ID: 33415725
    [No Abstract]   [Full Text] [Related]  

  • 30. Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings.
    Khan P; Aufdembrink LM; Engelhart AE
    ACS Synth Biol; 2020 Nov; 9(11):2861-2880. PubMed ID: 32966744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspective of Covid-19 pandemic in South Asian countries.
    Murtaza G; Imdad K; Arshad M; Hamza A; Aslam A; Bashir S
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13098-13100. PubMed ID: 33378063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacist's role in SARS-CoV-2 diagnostic testing.
    Goode JR; Page A; Burns A; Bernard S; Wheawill S; Gatewood SBS
    J Am Pharm Assoc (2003); 2020; 60(6):e19-e32. PubMed ID: 32883622
    [No Abstract]   [Full Text] [Related]  

  • 33. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
    Cook D
    BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318
    [No Abstract]   [Full Text] [Related]  

  • 34. Should COVID-19 testing programs also screen for HIV?
    Duong D
    CMAJ; 2021 May; 193(19):E702-E703. PubMed ID: 33972227
    [No Abstract]   [Full Text] [Related]  

  • 35. SARS-CoV-2 in Germany: Association between deaths and positive rate.
    Scherb H
    Eur J Clin Invest; 2021 Apr; 51(4):e13500. PubMed ID: 33497463
    [No Abstract]   [Full Text] [Related]  

  • 36. Breast cancer surgery during the COVID-19 pandemic.
    Highton LR; Dave RV; Barnes NLP
    Br J Surg; 2020 Sep; 107(10):e380. PubMed ID: 32779735
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional variation in trajectories of healthcare worker infections during the COVID-19 pandemic in Italy.
    Bellizzi S; Panu Napodano CM; Salaris P; Pichierri G; Sotgiu G
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1472-1474. PubMed ID: 32362294
    [No Abstract]   [Full Text] [Related]  

  • 38. Romeo and Juliet: Revisited (at the time of COVID-19).
    Costantino G; Peyvandi F; Montano N; Agostoni C
    Eur J Intern Med; 2020 Nov; 81():94. PubMed ID: 32653154
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19 and cancer in the United States.
    Grob S; Mucci LA
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):26-27. PubMed ID: 33412790
    [No Abstract]   [Full Text] [Related]  

  • 40. Healthcare worker infection with SARS-CoV-2 and test-based return to work.
    Shenoy ES; West LR; Hooper DC; Sheehan RR; Hashimoto D; Boukus ER; Aurora MN; McEvoy DS; Klompas M
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1464-1466. PubMed ID: 32843110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.